Page last updated: 2024-08-23

teprotide and Hematologic Malignancies

teprotide has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballestrero, A; Bello, C; Cea, M; Cirmena, G; Dal Bello, G; Duchosal, MA; Dupuis, M; Fruscione, F; Garuti, A; Grossi, F; Moran, E; Nahimana, A; Nencioni, A; Patrone, F; Pronzato, P; Rocco, I; Sordat, B; Vogel, P1

Other Studies

1 other study(ies) available for teprotide and Hematologic Malignancies

ArticleYear
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
    Bioorganic & medicinal chemistry, 2010, May-01, Volume: 18, Issue:9

    Topics: alpha-Mannosidase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Hematologic Neoplasms; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Teprotide

2010